Member Info for RichTheNewbie

Nolupus - no point carrying this on. Was just mildly amusing. You were hardly a beacon of positivity yesterday let's just agree on that ;)

With regards your BioBank comment - that would make sense - although I think there's little point focusing on this aspect unless there's reason to think it'll make serious money for SNG (which I see little reason to think based on the limited info so far).

Forgive me for finding it a bit amusing that you were cited as someone saying buy more it's going up when you were basically doing pretty much the exact opposite yesterday ;)

Now dropping in the delayed large buys from when the price was a few pence lower so they appear like sells to fool people ;)

I must have missed that in between all the posts of misery and saying this was going down. Lol.

Ask is now up to 42p....

ShareSting - there's not enough detail to know what SNG's part is. They might just be assisting with providing/collecting data (since they'll be collecting lots as part of their trials) or perhaps analysis of it due to their knowledge/experience. There's a good chance this isn't particularly material to the value of this company (and therefore not worthy of an RNS).

JSP123 - They're definitely not overpromotional.....but I like that. Some companies issue an RNS every two minutes, full of hype, full of empty promises and sky high predictions. SNG is the exact opposite and release news very rarely and is very straight to the point with no BS.

So, yeah they probably could do more media and hype things up more.....but there's no real point. If the results are good this will be the hottest property in town. If not then the hype would have been unjustified.

38p back on the bid and attacking 39p now.

I don't think anyone could state the pricing yet (maybe not even the CEO) not least because drugs are often charged at different amounts to different customers. It might be $1000 in the US but £100 for the NHS for example.

SNG001 (IFN-B) helps the body to properly fight off viruses without getting out of control.

- There's a pretty much completed trial which should hopefully show this has helped a meaningful amount of COPD patients from getting virus related exacerbations
- There are trials underway in COVID patients to show it can help them fight off the virus (split into two parts because of the increased chance of it helping in the earlier stages)
- Synairgen themselves have already tested hundreds of patients with the drug without and serious reported side effects
- Interferon beta itself is already used worldwide in other conditions safely (to quote the Multiple Sclerosis society talking about IFN-B: "Compared to other DMTs the risk of side effects, especially serious ones, is among the lowest. and many of those side effects they list appear to come as a result of the method of dosage - injection)
- Interferon beta has already been shown to have significant impact in recent trials of other drugs in combination studies with the IFN-B group doing far better
- The company raised £14m, in a placement not available to the public, and was quickly completed, with the company thanking their "new high quality specialist and generalist shareholders"
- The company allocated half the money to the COVID trials but perhaps more interestingly:
- Manufacture of SNG001 drug product and other supply chain considerations: £4m
- Strengthened balance sheet for potential partnering discussions with regards to the COVID-19, future pandemic preparedness, and the COPD opportunity, working capital and fees: £3m
- CEO said "'We are aiming to be in a position to provide millions of doses later this year"

Now maybe they'll be really unlucky and, contrary to all the existing evidence, the trials won't show any impact in any of the conditions. However all of the existing information suggests there's a high likelihood it will show impact, that the company believes it will, and that they're gearing up to produce and sell it on a mass scale, and be ready for the influx of partners/bids once the data has been released.

It's definitely not a sure thing.....but I'm not sure it could be looking any better.

John117 - Yeah, injecting yourself with disinfectant like Trump suggested, go straight to death and skip the hospital part ;)

Ghia - of course everyone always complies with the TR-1 system to the letter.....;)
The amount was extremely close to the notification threshold. For all we know they do it deliberately to avoid it. Maybe it went to somebody's broker who take a small portion of the shares as their cut for the deal and leaves it below the threshold. Who knows. Whatever it was - you're seeing deals for serious amounts at these levels.

johnygreenfeet - lol. That one did make me chuckle.

No point expecting a mention until data is confirmed showing efficacy (not impossible granted - but a lot more likely when that happens).
If you see all the press this is getting (which only works for late stage patients and stops a small chunk of them dying) imagine what the press coverage will be like for a treatment that can be given safely to everyone with earlier stage COVID, via a simple inhaler, to help fight off the virus and reduce the chance of them getting to a critical state.

Seb46 - well only for the better if splitting hairs.

That charts are meaningless and unreliable?

I'm perfectly calm Dave. Unlike the majority of the other recent posts which are a mixture of anger and confusion.

Nolupus - considering the price is basically near enough still at the placing price, and buying still going through now at 34.64p, I don't know why you're throwing the teddies out of the pram. If 10% doesn't matter then stop worring about less than 1%!

Dave it's really not that difficult. Engage your brain.
There's about 149m shares in issue.
3% of that is roughly 4.47m shares.
4.47m shares is roughly £1.56m at 35p.
Hence I said £1.5m to make it simple for you.
£1m not being notifiable.

Not sure how I can make it any clearer.

Nolupus if you can find someone to tell you the bottom on every share with absolute reliability then please let me know because I'd like to know as I'll be a billionaire within a week. As that person doesn't exist you've got to make your own mind up. I think 35p won't be too far off give or take 5p, so I think it's a decent price, and that's my choice. If you don't, then don't buy, or sell or your shares if you hold any. People are just inventing conspiracies not much better than ones about 9/11 or the moon landings purely based on the share price.